3-Bromopyruvate is known for glycolytic inhibitors. Potential target is hexoknase II and/or glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
|Catalog #||Material Name||Company Name||Solute/Solvent|
In vitro test:
Dissolve in distilled water to make a 0.5 M stock solution. Aliquote and store at -20 degree
1. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells. Science. 2009; 325:1555. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Wilson JK, Markowitz S, Zhou S, Diaz LA Jr, Velculescu V, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N.
|Whole Exome Enrichment|
|GenCapTM technology captures both strands of the Exome for superior evenness and reduced sequencing costs.|
|High quality Epitomics Rabbit Monoclonal Antibodies to EGFR, Akt, Her2, ATM, and More. Click here to learn more|
|From pipettes to automation to calibration, the total solution for all of your liquid handling needs.|